- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed or Refractory Hematologic Malignancies in Canada
Total 548 results
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Raewyn BroadyUnknown
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Beckman Coulter, Inc.Completed
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
Maisonneuve-Rosemont HospitalCanadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaboratorsCompletedHematologic MalignancyCanada
-
Alberta Health servicesUnknownHematologic MalignancyCanada
-
University of British ColumbiaCompletedHematological Malignancy | Bone Marrow Failure SyndromeCanada
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
The Hospital for Sick ChildrenBristol-Myers SquibbTerminatedRefractory or Recurrent Hypermutated Malignancies | Biallelic Mismatch Repair Deficiency (bMMRD) Positive PatientsUnited States, France, Canada, Australia, Israel
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Ottawa Hospital; Hamilton... and other collaboratorsCompletedHematologic MalignanciesCanada
-
Kiadis PharmaCompletedHematologic Diseases | Hematologic MalignanciesCanada
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
CASI Pharmaceuticals, Inc.CompletedMyelodysplasia | Hematological Malignancies | Agnogenic Myeloid MetaplasiaCanada
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
University Health Network, TorontoCompletedLymphoma | Leukemia | Myeloma | Hodgkin's DiseaseCanada
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
Mount Sinai Hospital, CanadaActive, not recruitingStem Cell Transplant | Hematologic MalignancyCanada
-
Mount Sinai Hospital, CanadaPrincess Margaret Hospital, CanadaActive, not recruitingHypoxia | Hematologic Malignancy | Immunocompromised | Post Hematopoietic Stem Cell Transplant | Pulmonary InfiltratesCanada
-
Ciusss de L'Est de l'Île de MontréalUnknownFebrile Neutropenia | Hematologic Malignancies | VancomycinCanada
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Ciusss de L'Est de l'Île de MontréalExCellThera inc.; Stem Cell NetworkActive, not recruitingCord Blood Transplant | High Risk Hematologic MalignancyCanada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Genzyme, a Sanofi Company; The...UnknownHematologic MalignanciesCanada
-
British Columbia Cancer AgencyCanadian Urologic Oncology Group; German Testicular Cancer Study Group; NCIC...CompletedRelapsed or Cisplatin-Refractory Germ Cell CancerCanada
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
Mount Sinai Hospital, CanadaActive, not recruitingThrombocytopenia | Hematologic Malignancy | Venous Thromboembolic Disease | Thrombosis, Venous | Bleeding HemorrhageCanada
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedMyeloablative Conditioning | HLA-mismatched Bone Marrow Transplantation | Graft Survival | Transplantation, Bone MarrowCanada, United States
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China